SBIR/STTR Research Award
SBIR Phase I: Rapid COVID-19 diagnostics with CMOS-integrated single-molecule field-effect transistors
Award amount
$255,678Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- QUICKSILVER BIOSCIENCES INC
- Proposal award date
- 2020-09-01
- Contract end date
- 2021-08-31
- UEI
- ZMEHBJ39DWK1
- Solicitation number
- Not reported
- Topic code
- DH
Research abstract
The broader impact / commercial potential of this Small Business Innovation Research (SBIR) Phase I Project is to reduce time-to-diagnosis for COVID-19 through the development of a novel all-electronic single-molecule molecular diagnostics platform. The
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array
- SBIR Phase I: Single-molecule field-effect transistor arrays for multiplexed genomic identification of infectious diseases
Research funding history
3 SBIR/STTR records share this UEI (2019–2022). Reported award amounts total $928,479. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II
Agencies: National Science Foundation, Department of Health and Human Services